Kelun Lifesciences (Pvt.) Ltd., a pharmaceutical manufacturing facility in Sri Lanka located at the Kandy Industrial Park, has fulfilled 40% of the total demand for saline in the country and saved over Rs. 1.5 billion through the manufacture of saline locally since 2017. 

This was revealed during an official visit to the industrial park by Investment Promotion State Minister Dilum Amunugama, Board of Investment (BOI) Director General Renuka M. Weerakone, and Executive Director (Zones) M.K.D. Lawrance.

Addressing the investors, Amunugama stated: “It is evident and undeniable that local productions and exports have been largely hit by global and local recessions resulting in low production and exports.”

The State Minister proceeded to say that the Investment Promotion Ministry is in the process of making short-term and long-term strategies to address the contemporary issues confronted by industry players so that they could carry on the operations without a hitch. 

“In this context, the Government is keen on taking pertinent measures to ensure the smooth operation of the local industries in the face of the global and local economic setbacks,” he underscored.

During the visit, the State Minister chaired a meeting with the participation of investors of the industrial park, to discuss and iron out issues faced by them.

The Kandy Industrial Park, situated over a 114-acre area of land, houses 24 factories with a worker population of over 10,400.

Kelun Lifesciences, an Indian investment, commenced operations in 2017. A total of 230 employees are currently employed at the factory.